hesperetin has been researched along with Cancer of Stomach in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HW; Kim, JB; Kim, SH; Woo, HJ; Yang, JY | 1 |
| Sheng, H; Wang, SW; Zhang, F; Zheng, F | 1 |
| Dong, W; Song, J; Wang, J; Wu, D; Yi, J; Zhang, J | 1 |
| Chen, H; Kunnimalaiyaan, M; Pinchot, SN; Zarebczan, B | 1 |
4 other study(ies) available for hesperetin and Cancer of Stomach
| Article | Year |
|---|---|
Hesperetin Inhibits Expression of Virulence Factors and Growth of
Topics: Bacterial Proteins; Blotting, Western; Flavanones; Helicobacter Infections; Helicobacter pylori; Hesperidin; Stomach Neoplasms; Virulence Factors | 2021 |
Hesperetin promotes DOT1L degradation and reduces histone H3K79 methylation to inhibit gastric cancer metastasis.
Topics: Animals; Hesperidin; Histone-Lysine N-Methyltransferase; Histones; Humans; Methylation; Mice; Mice, Nude; Stomach Neoplasms | 2021 |
Hesperetin Induces the Apoptosis of Gastric Cancer Cells via Activating Mitochondrial Pathway by Increasing Reactive Oxygen Species.
Topics: Analysis of Variance; Animals; Apoptosis; Blotting, Western; Cell Proliferation; Female; Hesperidin; Heterografts; Humans; In Situ Nick-End Labeling; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Reactive Oxygen Species; Reference Values; Stomach Neoplasms; Tumor Cells, Cultured | 2015 |
Hesperetin, a potential therapy for carcinoid cancer.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; Carcinoid Tumor; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Hesperidin; Humans; Polymerase Chain Reaction; Receptor, Notch1; Signal Transduction; Stomach Neoplasms; Transcriptional Activation; Up-Regulation | 2011 |